DCPH - Deciphera Pharmaceuticals Inc. (DCPH) CEO Steven Hoerter on Q1 2021 Results - Earnings Call Transcript

Deciphera Pharmaceuticals, Inc. (DCPH) Q1 2021 Earnings Conference Call May 4, 2021 16:30 ET Company Participants Jen Robinson - Vice President, Investor Relations Steven Hoerter - President & Chief Executive Officer Daniel Martin - Chief Commercial Officer Matthew Sherman - Chief Medical Officer Tucker Kelly - Executive Vice President & Chief Financial Officer Conference Call Participants Daniel Wolle - JPMorgan Chris Raymond - Piper Sandler Eun Yang - Jefferies Michael Schmidt - Guggenheim Reni Benjamin - JMP Securities Peter Lawson - Barclays Presentation Operator Good afternoon, everyone and welcome to Deciphera Pharmaceuticals First Quarter 2021 Financial Results Conference call. Today's call is being recorded. At this time, I would like to hand the conference over to Jen Robinson, Vice President of Investor Relations. You may begin. Jen Robinson Thank you, Tolanda. Welcome and thank you for joining us today to discuss Deciphera's first quarter 2021 financial results. I'm Jen Robinson,

For further details see:

Deciphera Pharmaceuticals, Inc. (DCPH) CEO Steven Hoerter on Q1 2021 Results - Earnings Call Transcript